Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

“Drug Watch” Website Included In FDA’s Rx Safety Reforms

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA will launch a Drug Watch website as part of its drug safety reform initiative
Advertisement

Related Content

FDA To Name IoM Safety Review Committee Members April 18
FDA To Name IoM Safety Review Committee Members April 18
Bextra Decision Shows Effort To Improve Drug Safety Transparency, FDA Says
FDA Drug Safety Website Could Cause More Harm Than Good, Novartis Says
FDA Deputy Commissioner Sachdev Departs Ahead Of Crawford Confirmation
AstraZeneca Seeks Cmte. Input On Further Iressa Marketing Steps
FDA Drug Watch Website Coming "Soon"
FDA Drug Safety Oversight Board Will Include VA, Other Agencies
FDA Drug Safety Oversight Board Will Include VA, Other Agencies
FDA Drug Safety Initiative Will Include New Website On Rx Risks

Topics

Advertisement
UsernamePublicRestriction

Register

PS061547

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel